论文部分内容阅读
目的:探讨氯沙坦钾片治疗社区高血压并高尿酸血症的临床疗效。方法:选择2012年3月-2014年3月期间我社区医院治疗的高血压并高尿酸血症患者70例,根据随机数字表法将其平均分为研究组与对照组,每组各35例。研究组患者口服氯沙坦钾片治疗,对照组患者口服左旋氨氯地平分散片治疗。结果:研究组治疗的总有效率为94.29%,显著高于对照组的74.29%,两组对比差异具有统计学意义(P<0.05)。结论:氯沙坦钾片治疗高血压并高尿酸血症,疗效确切,不仅有效降低了患者的血压水平,同时也降低了血尿酸值,保障了患者的健康及生活质量,适于临床应用。
Objective: To investigate the clinical efficacy of losartan potassium in the treatment of community-based hypertension and hyperuricemia. Methods: Seventy patients with hypertension and hyperuricemia who were treated in our community hospital from March 2012 to March 2014 were randomly divided into study group and control group according to random number table method, with 35 cases in each group . Patients in the study group were treated with losartan potassium tablets orally and patients in the control group were treated with oral levamlodipine dispersible tablets. Results: The total effective rate of the study group was 94.29%, which was significantly higher than that of the control group (74.29%). The difference between the two groups was statistically significant (P <0.05). Conclusion: Losartan potassium tablets for hypertension and hyperuricemia, the exact effect, not only effectively reduce the patient’s blood pressure levels, but also reduce the blood uric acid value, protect the patient’s health and quality of life, suitable for clinical applications.